# AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

Study · id `cardio:ct-nct03732794` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03732794](<https://clinicaltrials.gov/study/NCT03732794>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03732794

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 150 participants.

## Technical summary

Registry record NCT03732794. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01-30 (actual); primary completion 2024-06-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT03732794, source copy `cardio:ctgov-nct03732794-2024-10-15`, retrieved 2026-10-26)
- Started: 2019-01-30 (actual) (ClinicalTrials.gov record NCT03732794, source copy `cardio:ctgov-nct03732794-2024-10-15`, retrieved 2026-10-26)
- Primary completion: 2024-06-27 (actual) (ClinicalTrials.gov record NCT03732794, source copy `cardio:ctgov-nct03732794-2024-10-15`, retrieved 2026-10-26)
- Completion: 2026-06 (anticipated) (ClinicalTrials.gov record NCT03732794, source copy `cardio:ctgov-nct03732794-2024-10-15`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03732794, source copy `cardio:ctgov-nct03732794-2024-10-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03732794-2024-10-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
- Acronym: ICE-AFIB
- Condition: Atrial Fibrillation (AF)
- Condition: Persistent Atrial Fibrillation
- Condition: Longstanding Persistent Atrial Fibrillation
- Intervention (Device): AtriCure CryoICE & AtriClip LAA Exclusion
- Lead sponsor: AtriCure, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: AtriCure, Inc. (`cardio:org-atricure-inc`)

## Provenance

Content hash: 42b124a0074a7ba3a85cb8a0fabbd3573a288c0d0598e17a4250a06853997315
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
